Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) (CONVOY)

AstraZeneca

Status: Completed

Conditions: Osteoarthritis; Ankylosing Spondylitis; Rheumatoid Arthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT01519375

NIS-RSE-ATC-2011/1

Details and patient eligibility

About

The primary objective of this cross-sectional observational real life study is to investigate the patient reported adherence to PPI, when prescribed as prevention of NSAID associated GI Ulcers to patients prescribed a NSAID. Patients included have Osteoarthritis, Rheumatoid Arthritis or Ankylosing Spondylitis. Adherence will be assessed by patient questionnaires.

Full description

Cross-sectional, observational Real Life study on NSAIDs treated patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of patient adherence to PPI treatment

Enrollment: 102 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed diagnosis (documented in the medical record) of OA, RA or AS
• Prescription of oral NSAID treatment for OA, RA or AS, where low dose is not sufficient
• Prescription of PPI for prevention of NSAID associated GI ulcers, with instruction to take PPI same day as when taking NSAID.

Exclusion criteria

• Participating in any clinical trial involving PPI or NSAID
• Patients prescribed PPI as acute treatment of GI events or symptoms within 8 weeks
• Inability to complete PROs

Trial design

102 participants in 1 patient group

1

Description:

Patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis, 18 years or older